Cargando…
Development of lacosamide for the treatment of partial-onset seizures
Lacosamide is an antiepileptic drug (AED) available in multiple formulations that was first approved in 2008 as adjunctive therapy for partial-onset seizures (POS) in adults. Unlike traditional sodium channel blockers affecting fast inactivation, lacosamide selectively enhances sodium channel slow i...
Autores principales: | Doty, Pamela, Hebert, David, Mathy, Francois-Xavier, Byrnes, William, Zackheim, James, Simontacchi, Kelly |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3759704/ https://www.ncbi.nlm.nih.gov/pubmed/23859801 http://dx.doi.org/10.1111/nyas.12213 |
Ejemplares similares
-
Lacosamide for the prevention of partial onset seizures in epileptic adults
por: Kelemen, Anna, et al.
Publicado: (2010) -
Lacosamide adjunctive therapy for partial-onset seizures: a meta-analysis
por: Sawh, Sonja C., et al.
Publicado: (2013) -
Novel nasal niosomes loaded with lacosamide and coated with chitosan: A possible pathway to target the brain to control partial-onset seizures
por: Tulbah, Alaa S., et al.
Publicado: (2023) -
Refractory Ventricular Tachycardia and Seizures With Lacosamide Overdose
por: Marcellino, Chris, et al.
Publicado: (2022) -
Efficacy and tolerability of lacosamide as adjunctive therapy in patients with focal-onset seizures: an observational, prospective study
por: Jin, Yang, et al.
Publicado: (2023)